Jennifer Lin to Cost-Benefit Analysis
This is a "connection" page, showing publications Jennifer Lin has written about Cost-Benefit Analysis.
Connection Strength
0.025
-
Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. J Natl Cancer Inst. 2012 Dec 05; 104(23):1785-95.
Score: 0.025